Search clinical trials for: Gastroenteropancreatic Neuroendocrine Tumors
Total 16000 results
-
IpsenCompletedGastro-Enteropancreatic Neuroendocrine TumorUnited States, Austria, Denmark
-
Novartis PharmaceuticalsCompletedGastroenteropancreatic Neuroendocrine Tumor of the Pulmonary ot Gastroenteropancreatic SystemGermany
-
H. Lee Moffitt Cancer Center and Research InstituteTerminatedPancreatic Cancer | Gastro-enteropancreatic Neuroendocrine Tumor | Neuroendocrine Carcinomas of Pancreas | Islet Cell CarcinomaUnited States
-
AbbVieTerminatedGlioblastoma | Medullary Thyroid Cancer | Malignant Melanoma | Other Solid Tumors | Large-Cell Neuroendocrine Carcinoma | Neuroendocrine Prostate Cancer | High Grade Gastroenteropancreatic Neuroendocrine Carcinoma | Other Neuroendocrine CarcinomaUnited States
-
H. Lee Moffitt Cancer Center and Research InstitutePharmacyclics LLC.CompletedCarcinoid Tumors | Pancreatic NETUnited States
-
IpsenCompletedGastroenteropancreatic Neuroendocrine TumorsUnited States
-
IpsenCompletedGastroenteropancreatic Neuroendocrine TumoursSweden
-
Haukeland University HospitalUllevaal University Hospital; Aarhus University Hospital; Rigshospitalet, Denmark and other collaboratorsCompletedNeuroendocrine CarcinomaNorway
-
IpsenCompletedGastroenteropancreatic Neuroendocrine TumorsSwitzerland
-
Gabrail Cancer Center ResearchKaryopharm Therapeutics IncCompletedCarcinoma, NeuroendocrineUnited States
-
IpsenCompletedGastroenteropancreatic Neuroendocrine TumorsGermany, Austria
-
Hospices Civils de LyonUnknownMetastatic Cancer | Gastro-enteropancreatic Neuroendocrine Tumor | Health Care CostsFrance
-
Jiangsu HengRui Medicine Co., Ltd.Cancer Institute and Hospital, Chinese Academy of Medical SciencesTerminatedGastroenteropancreatic Neuroendocrine TumorChina
-
IpsenCompletedGastroenteropancreatic Neuroendocrine TumorUnited States
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.UnknownGastroenteropancreatic Neuroendocrine Tumor G3China
-
University Hospital Inselspital, BerneUniversity Hospital, Basel, Switzerland; University of Lausanne Hospitals; University... and other collaboratorsTerminatedGastroenteropancreatic Neuroendocrine TumorsSwitzerland
-
National Cancer Institute, NaplesFederico II University; University of Campania "Luigi Vanvitelli"Terminated
-
Novartis PharmaceuticalsCompletedSymptomatic Refractory Resistant Carcinoid DiseaseUnited Kingdom, Belgium, Italy, Singapore, Austria, France, Israel, Sweden, Germany, Spain, Canada, Argentina, Poland, United States, Brazil, Norway
-
M.D. Anderson Cancer CenterNot yet recruitingUnresectable MelanomaUnited States
-
University Hospital, Basel, SwitzerlandNot yet recruitingNeuroendocrine TumorsSwitzerland
-
PfizerRecruitingMelanoma | Colorectal Cancer | Non-Small Cell Lung Cancer | Urothelial Cancer | Advanced or Metastatic Solid TumorsUnited States, Puerto Rico
-
Memorial Sloan Kettering Cancer CenterNeuroEndocrine Tumor Research Foundation (NETRF)RecruitingNeuroendocrine TumorsUnited States
-
University Hospital, MontpellierNot yet recruiting
-
KaliVir ImmunotherapeuticsNot yet recruitingKidney Cancer | Renal Cell Carcinoma | Cervical Cancer | Mesothelioma | Non-small Cell Lung Cancer | Head and Neck Squamous Cell Carcinoma | Solid Tumor, Adult | Microsatellite Stable Colorectal Cancer | Melanoma Stage IV | Merkel Cell Carcinoma of Skin
-
Radboud University Medical CenterNot yet recruitingPheochromocytoma | Paraganglioma
-
ITM Solucin GmbHNot yet recruitingLymphoma | CNS Tumor | Solid Tumor, Childhood | Somatostatin Receptor Positive | NET
-
University of UtahGeorgetown University; West Virginia UniversityRecruiting
-
Suzhou Zelgen Biopharmaceuticals Co.,LtdNot yet recruiting
-
King's College Hospital NHS TrustRecruitingPheochromocytoma | ParagangliomaUnited Kingdom
-
Duke UniversityNot yet recruitingOcular Melanoma
-
Centre Hospitalier Universitaire DijonRecruitingNeuroendocrine Tumors | MEN1 MutationFrance
-
Sun Yat-sen UniversityChia Tai Tianqing Pharmaceutical Group Co., Ltd.Recruiting
-
National Cancer Institute (NCI)Not yet recruitingPheochromocytoma | Somatostatin Receptor Positive | Paragangliomas | Gastrointestinal Neuroendocrine TumorsUnited States
-
Georgiamune IncRecruitingSolid Tumor | Melanoma Stage IVUnited States
-
Peking University Cancer Hospital & InstituteNot yet recruitingMelanoma | Metastatic Melanoma | Mucosal MelanomaChina
-
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co...Not yet recruitingAdvanced Solid Tumor, SCLC(Small Cell Lung Cancer) or LCNEC (Large Cell Neuroendocrine Carcinoma)China
-
Peking Union Medical College HospitalRecruitingLymphoma | Thymic Epithelial Tumor | Teratoma | Schwannoma | Germ Cell Tumor | Thymic Cyst | Retrosternal GoitreChina
-
Gruppo Oncologico Italiano di Ricerca ClinicaRecruitingPulmonary Large-cell Neuroendocrine CarcinomaItaly
-
Thomas Jefferson UniversityNot yet recruitingLocally Advanced Unresectable Uveal MelanomaUnited States
-
Royal Marsden NHS Foundation TrustNot yet recruiting
-
Assistance Publique - Hôpitaux de ParisCentre Leon Berard; Institut National de la Santé Et de la Recherche Médicale... and other collaboratorsNot yet recruitingEnvironmental Exposure | SDH Gene Mutation | SDH-Related Familial Paraganglioma | SDHx-Related SyndromesFrance
-
Azienda Ospedaliera Universitaria Integrata VeronaNot yet recruitingPancreatic Neuroendocrine Tumor
-
National Cancer Institute (NCI)Not yet recruitingCarcinoma, Neuroendocrine | Tumor, Neuroendocrine | Tumors, Neuroendocrine | Neuroendocrine; Carcinoma | Small Cell; ReceptorsUnited States
-
Fondazione Policlinico Universitario Agostino Gemelli...RecruitingNeuroendocrine Tumors | Pulmonary Neuroendocrine Neoplasm | Gep NetItaly
-
European Institute of OncologyRecruitingNeuroendocrine CarcinomaItaly
-
University of Texas Southwestern Medical CenterRecruitingMelanoma (Skin)United States
-
Sinotau Pharmaceutical GroupNot yet recruitingAdvanced Neuroendocrine NeoplasmChina
-
Rise Therapeutics LLCNot yet recruitingMelanoma | Basal Cell Carcinoma | Squamous Cell Carcinoma | Melanoma Recurrent | Squamous Cell Cancer | Basal Cell Cancer
-
University of IowaNovartisNot yet recruitingNeuroendocrine Tumors | Neuroendocrine Tumor Grade 2 | Neuroendocrine Tumor Grade 1United States